Are you Dr. Amin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Hesham Amin, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Illinois. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Loyola University Medical CenterFellowship, Hematopathology, 2000 - 2001- Loyola University Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2000
George Washington University School of MedicineInternship, Transitional Year, 1996 - 1997
Cairo University School of MedicineClass of 1982
Certifications & Licensure
IL State Medical License 2000 - 2026
TX State Medical License 2002 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.Shadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, Sunyoung S Lee, James C Yao
Journal of Immunotherapy and Precision Oncology. 2024-11-01 - Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, Lianchun Xiao, Elshad Hasanov
Oncology. 2024-10-18 - Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.Manal M Hassan, Donghui Li, Younghun Han, Jinyoung Byun, Rikita I Hatia
Hepatology. 2024-07-01
Press Mentions
The C-jun and JunB Transcription Factors Facilitate the Transit of Classical Hodgkin Lymphoma Tumour Cells Through G1October 30th, 2018
Pioneering Alum's $10.5 Million Gift Boosts Biomedical Research at Houston Graduate SchoolJune 26th, 2017- Kopchicks' $10.5 Million Gift to Fund Student Fellowships at MD Anderson UTHealth Graduate SchoolJune 22nd, 2017
Grant Support
- Role Of IGF-IR Tyrosine Kinase In Npm-Alk-Expressing T-Cell LymphomaNational Cancer Institute2011
- Role Of JAK3 In Anaplastic Large Cell LymphomaNational Cancer Institute2006–2008
